IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent smad signaling

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2814-2823

  Liu, Yan ^a   Meyer, Christoph ^a   Müller, Alexandra ^a   Herweck, Frank ^a   Li, Qi ^a   Müllenbach, Roman ^a,b   Mertens, Peter R ^c   Dooley, Steven ^a   Weng, Hong Lei ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 13; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SMAD1 PROTEIN; SMAD2 PROTEIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; IMMUNOMODULATION; LIVER FIBROSIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; BLOTTING, WESTERN; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATIC STELLATE CELLS; HUMANS; INTERLEUKIN-13; LIVER CIRRHOSIS; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 80052654374     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003260     Document Type: Article

References (54)

1. Iredale, J. P. 2007. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117: 539-548. (Pubitemid 46348508)
2. Friedman, S. L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669. (Pubitemid 351615417)
3. Dooley, S., J. Hamzavi, K. Breitkopf, E. Wiercinska, H. M. Said, J. Lorenzen, P. Ten Dijke, and A. M. Gressner. 2003. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125: 178-191. (Pubitemid 36799118)
4. Gressner, A. M., R. Weiskirchen, K. Breitkopf, and S. Dooley. 2002. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7: d793-d807.
5. Bissell, D. M., D. Roulot, and J. George. 2001. Transforming growth factor beta and the liver. Hepatology 34: 859-867. (Pubitemid 33032019)
6. Moustakas, A., S. Souchelnytskyi, and C. H. Heldin. 2001. Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114: 4359-4369. (Pubitemid 34082857)
7. Wynn, T. A. 2003. IL-13 effector functions. Annu. Rev. Immunol. 21: 425-456. (Pubitemid 37174537)
8. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594.
9. Wynn, T. A. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214: 199-210. (Pubitemid 351160157)
10. McKenzie, A. N., J. A. Culpepper, R. De Waal Malefyt, F. Brière, J. Punnonen, G. Aversa, A. Sato, W. Dang, B. G. Cocks, S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90: 3735-3739. (Pubitemid 23111442)
11. Minty, A., P. Chalon, J. M. Derocq, X. Dumont, J. C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248-250. (Pubitemid 23093630)
12. Punnonen, J., G. Aversa, B. G. Cocks, A. N. McKenzie, S. Menon, G. Zurawski, R. De Waal Malefyt, and J. E. De Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90: 3730-3734. (Pubitemid 23111441)
13. Zurawski, S. M., F. Vega, Jr., B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12: 2663-2670. (Pubitemid 23218315)
14. Fallon, P. G., E. J. Richardson, G. J. McKenzie, and A. N. McKenzie. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164: 2585-2591. (Pubitemid 30115489)
15. Chiaramonte, M. G., D. D. Donaldson, A. W. Cheever, and T. A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104: 777-785. (Pubitemid 29536363)
16. Kolodsick, J. E., G. B. Toews, C. Jakubzick, C. Hogaboam, T. A. Moore, A. McKenzie, C. A. Wilke, C. J. Chrisman, and B. B. Moore. 2004. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172: 4068-4076. (Pubitemid 38375218)
17. Lanone, S., T. Zheng, Z. Zhu, W. Liu, C. G. Lee, B. Ma, Q. Chen, R. J. Homer, J. Wang, L. A. Rabach, et al. 2002. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110: 463-474. (Pubitemid 34919700)
18. Shimamura, T., T. Fujisawa, S. R. Husain, M. Kioi, A. Nakajima, and R. K. Puri. 2008. Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J. Immunol. 181: 4656-4665.
19. Kaviratne, M., M. Hesse, M. Leusink, A. W. Cheever, S. J. Davies, J. H. McKerrow, L. M. Wakefield, J. J. Letterio, and T. A. Wynn. 2004. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173: 4020-4029. (Pubitemid 39280766)
20. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16: 137-161.
21. Daniels, C. E., M. C. Wilkes, M. Edens, T. J. Kottom, S. J. Murphy, A. H. Limper, and E. B. Leof. 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114: 1308-1316. (Pubitemid 40385302)
22. Gressner, O. A., and A. M. Gressner. 2008. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 28: 1065-1079.
23. Gressner, O. A., B. Lahme, M. Siluschek, K. Rehbein, R. Weiskirchen, and A. M. Gressner. 2009. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes - but without modulating bone morphogenetic protein 7 signaling. Hepatology 49: 2021-2030.
24. Wahab, N. A., N. Yevdokimova, B. S. Weston, T. Roberts, X. J. Li, H. Brinkman, and R. M. Mason. 2001. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem. J. 359: 77-87. (Pubitemid 32939209)
25. Riser, B. L., M. Denichilo, P. Cortes, C. Baker, J. M. Grondin, J. Yee, and R. G. Narins. 2000. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J. Am. Soc. Nephrol. 11: 25-38. (Pubitemid 30020423)
26. Grotendorst, G. R. 1997. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8: 171-179. (Pubitemid 28077925)
27. Leask, A., and D. J. Abraham. 2004. TGF-beta signaling and the fibrotic response. FASEB J. 18: 816-827.
28. Leask, A., C. P. Denton, and D. J. Abraham. 2004. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J. Invest. Dermatol. 122: 1-6. (Pubitemid 38114631)
29. Sedlaczek, N., J. D. Jia, M. Bauer, H. Herbst, M. Ruehl, E. G. Hahn, and D. Schuppan. 2001. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am. J. Pathol. 158: 1239-1244. (Pubitemid 32281287)
30. Weng, H. L., L. Ciuclan, Y. Liu, J. Hamzavi, P. Godoy, H. Gaitantzi, S. Kanzler, R. Heuchel, U. Ueberham, R. Gebhardt, et al. 2007. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46: 1257-1270. (Pubitemid 350144790)
31. Grotendorst, G. R., H. Okochi, and N. Hayashi. 1996. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7: 469-480. (Pubitemid 26362091)
32. Gressner, O. A., B. Lahme, I. Demirci, A. M. Gressner, and R. Weiskirchen. 2007. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J. Hepatol. 47: 699-710. (Pubitemid 47503426)
33. Weng, H. L., Y. Liu, J. L. Chen, T. Huang, L. J. Xu, P. Godoy, J. H. Hu, C. Zhou, F. Stickel, A. Marx, et al. 2009. The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50: 230-243.
34. Schäfer, S., O. Zerbe, and A. M. Gressner. 1987. The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7: 680-687. (Pubitemid 17130709)
35. Hershey, G. K. 2003. IL-13 receptors and signaling pathways: an evolving web. J. Allergy Clin. Immunol. 111: 677-690, quiz 691.
36. Zurawski, S. M., P. Chomarat, O. Djossou, C. Bidaud, A. N. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270: 13869-13878.
37. Dooley, S., J. Hamzavi, L. Ciuclan, P. Godoy, I. Ilkavets, S. Ehnert, E. Ueberham, R. Gebhardt, S. Kanzler, A. Geier, et al. 2008. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135: 642-659.
38. Shi, Y., and J. Massagué. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
39. Ishisaki, A., K. Yamato, S. Hashimoto, A. Nakao, K. Tamaki, K. Nonaka, P. ten Dijke, H. Sugino, and T. Nishihara. 1999. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J. Biol. Chem. 274: 13637-13642.
40. Miyazono, K., Y. Kamiya, and M. Morikawa. 2010. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147: 35-51.
41. Blease, K., J. M. Schuh, C. Jakubzick, N. W. Lukacs, S. L. Kunkel, B. H. Joshi, R. K. Puri, M. H. Kaplan, and C. M. Hogaboam. 2002. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am. J. Pathol. 160: 481-490. (Pubitemid 34160325)
42. Chung, A. C., H. Zhang, Y. Z. Kong, J. J. Tan, X. R. Huang, J. B. Kopp, and H. Y. Lan. 2010. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J. Am. Soc. Nephrol. 21: 249-260.
43. Li, J. H., X. R. Huang, H. J. Zhu, M. Oldfield, M. Cooper, L. D. Truong, R. J. Johnson, and H. Y. Lan. 2004. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 18: 176-178.
44. Zhou, G., C. Li, and L. Cai. 2004. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am. J. Pathol. 165: 2033-2043. (Pubitemid 39578381)
45. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194: 809-821. (Pubitemid 32983016)
46. Weng, H., P. R. Mertens, A. M. Gressner, and S. Dooley. 2007. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J. Hepatol. 46: 295-303. (Pubitemid 44959156)
47. Goumans, M. J., F. Lebrin, and G. Valdimarsdottir. 2003. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc. Med. 13: 301-307. (Pubitemid 37159396)
48. Goumans, M. J., G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, C. Mummery, S. Karlsson, and P. ten Dijke. 2003. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 12: 817-828. (Pubitemid 37352776)
49. Goumans, M. J., G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21: 1743-1753. (Pubitemid 34614630)
50. Yu, P. B., C. C. Hong, C. Sachidanandan, J. L. Babitt, D. Y. Deng, S. A. Hoyng, H. Y. Lin, K. D. Bloch, and R. T. Peterson. 2008. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4: 33-41. (Pubitemid 350273653)
51. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, and T. A. Wynn. 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197: 687-701. (Pubitemid 36350864)
52. Lakkis, F. G., E. N. Cruet, G. M. Nassar, K. F. Badr, and D. W. Pascual. 1997. Expression of recombinant rat interleukin-13 (IL-13) and generation of a neutralizing rat IL-13 antiserum. Biochem. Biophys. Res. Commun. 235: 529-532. (Pubitemid 27326514)
53. Lauder, A., and A. N. McKenzie. 2002. Measurement of interleukin-13. Curr. Protoc. Immunol. Chapter 6:Unit 6.18.
54. Miller, R., R. Sadhukhan, and C. Wu. 2008. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay. J. Immunol. Methods 334: 134-141.